@article{09f38810450549dbbc00c72728fb3b3c,
title = "Sleep myths: an expert-led study to identify false beliefs about sleep that impinge upon population sleep health practices",
abstract = "Introduction: False beliefs about sleep can persist despite contradicting scientific evidence, potentially impairing population health. Identifying commonly held false beliefs lacking an evidence base (“myths”) can inform efforts to promote population sleep health. Method: We compiled a list of potential myths using Internet searches of popular press and scientific literature. We used a Delphi process with sleep experts (n = 10) from the fields of sleep medicine and research. Selection and refinement of myths by sleep experts proceeded in 3 phases, including focus groups (Phase 1); email-based feedback to edit, add, or remove myths (Phase 2); and closed-ended questionnaires (Phase 3) where experts rated myths on 2 dimensions, falseness and public health significance, using 5-point Likert scale from 1 (“not at all”) to 5 (“extremely false”). Results: The current study identified 20 sleep myths. Mean expert ratings of falseness ranged from 5.00 (SD = 0.00) for the statement “during sleep the brain is not active” to 2.50 (SD = 1.07) for the statement “sleeping in during the weekends is a good way to ensure you get adequate sleep.” Mean responses to public health significance ranged from 4.63 (SD = 0.74) for debunking the statement that “many adults need only 5 or less hours of sleep for general health” to 1.71 (SD = 0.49) for the statement that “remembering your dreams is a sign of a good night's sleep.” Conclusion: The current study identified commonly held sleep myths that have a limited or questionable evidence base. Ratings provided by experts suggest areas that may benefit from public health education to correct myths and promote healthy sleep.",
keywords = "Circadian timing, Population health, Sleep deficiency, Sleep health, Sleep medicine, Social psychology",
author = "Rebecca Robbins and Grandner, {Michael A.} and Buxton, {Orfeu M.} and Lauren Hale and Buysse, {Daniel J.} and Knutson, {Kristen L.} and Patel, {Sanjay R.} and Troxel, {Wendy M.} and Youngstedt, {Shawn D.} and Czeisler, {Charles A.} and Girardin Jean-Louis",
note = "Funding Information: Dr. Buysse reports personal fees from BeHealth, personal fees from Emmi Solutions, personal fees from American Academy of Physician Assistants, personal fees from Bayer, personal fees from CME Institute, personal fees from Ebb Therapeutics, outside the submitted work; In addition, Dr. Buysse has a patent Copyright pending. Dr. Buysse reports personal fees from BeHealth, personal fees from Emmi Solutions, personal fees from American Academy of Physician Assistants, personal fees from Bayer, personal fees from CME Institute, personal fees from Ebb Therapeutics, outside the submitted work; In addition, Dr. Buysse has a patent Copyright issued. Dr. Czeisler reports grants from Cephalon Inc., Jazz Pharmaceuticals Plc., Inc., National Football League Charities, Optum, Philips Respironics, Inc., Regeneron Pharmaceuticals, ResMed Foundation, San Francisco Bar Pilots, Sanofi S.A., Sanofi-Aventis, Inc, Schneider Inc., Sepracor, Inc, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, Sysco, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries, Ltd., and Wake Up Narcolepsy; and personal fees from Bose Corporation, Boston Celtics, Boston Red Sox, Cephalon, Inc., Columbia River Bar Pilots, Gan{\'e}sco Inc., Institute of Digital Media and Child Development, Klarman Family Foundation, Samsung Electronics, Quest Diagnostics, Inc, Teva Pharma Australia, Vanda Pharmaceuticals, Washington State Board of Pilotage Commissioners, Zurich Insurance Company, Ltd. In addition, Dr. Czeisler holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker), and holds an equity interest in Vanda Pharmaceuticals, Inc. Since 1985, Dr. Czeisler has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Casper Sleep Inc., Comair/Delta Airlines, Complete General Construction Company, FedEx, Greyhound, HG Energy LLC, Purdue Pharma, LP, South Carolina Central Railroad Co., Steel Warehouse Inc., Stric-Lan Companies LLC, Texas Premier Resource LLC and United Parcel Service (UPS). Dr. Czeisler receives royalties from the New England Journal of Medicine; McGraw Hill; Houghton Mifflin Harcourt/Penguin; and Philips Respironics, Inc. for the Actiwatch-2 and Actiwatch-Spectrum devices. Dr. Czeisler's interests were reviewed and managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies. Funding Information: This work was supported by NIH grants K07AG052685 (GJL); R01MD007716 (GJL); R25HL116378 (RR and GJL); R01 HD073352 and R01 HL122460 (LH); HL112646 (WT). Funding Information: This work was supported by NIH grants K07AG052685 (GJL) ; R01MD007716 (GJL) ; R25HL116378 (RR and GJL) ; R01 HD073352 and R01 HL122460 (LH) ; HL112646 (WT). Funding Information: Dr. Patel has received grant funding through his institution from the American Sleep Medicine Foundation, Bayer Pharmaceuticals, and Philips Respironics, personal consulting fees from the American Academy of Sleep Medicine, and serves on the Board of Directors of the American Thoracic Society and Breathe Pennsylvania. Publisher Copyright: {\textcopyright} 2019 National Sleep Foundation.",
year = "2019",
month = aug,
doi = "10.1016/j.sleh.2019.02.002",
language = "English (US)",
volume = "5",
pages = "409--417",
journal = "Sleep Health",
issn = "2352-7218",
publisher = "Elsevier Inc.",
number = "4",
}